Press

David Berry, MD PhD
Featured on
https://spac1.averincapital.com/pressreleases/detail/6949616d-1d8c-411e-a216-f795b49704b1
Insights

Averin Capital Acquisition Corp. Announces the Pricing of $250M IPO

New York, NY, Feb. 18, 2026 (GLOBE NEWSWIRE) — Averin Capital Acquisition Corp. (the ​“Company”) announced today the pricing of its initial public offering of 25,000,000 units at a price of $10.00 per unit. The units are expected to be listed on the Nasdaq Global Market (“Nasdaq”) and begin trading on February 19, 2026, under the ticker symbol ​“ACAAU.”

by David Berry, MD PhD
https://​spac1​.aver​in​cap​i​tal​.com/​p​r​e​s​s​r​e​l​e​a​s​e​s​/​d​e​t​a​i​l​/​6​9​4​9​6​1​6​d​-​1​d​8​c​-​4​1​1​e​-​a​2​1​6​-​f​7​9​5​b​4​9​704b1

Recent press

  5. Press

    AI's Leap in Biotech

    by David Berry, MD PhD

    Insights from "AI's Leap in Biotech" panel at Averin Capital